ProfileGDS4718 / 217628_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 85% 38% 79% 80% 56% 55% 81% 81% 81% 85% 79% 74% 52% 62% 58% 65% 63% 28% 30% 81% 74% 82% 78% 83% 63% 72% 55% 74% 52% 61% 47% 77% 83% 65% 25% 68% 74% 79% 31% 81% 54% 48% 56% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.4782977
GSM549102patient 115, normal, homogenized [OPG study]8.3568585
GSM549104patient 119, normal, homogenized [OPG study]4.9077438
GSM549108patient 138, normal, homogenized [OPG study]7.6165579
GSM549119patient 077, normal, homogenized [OPG study]7.7569680
GSM549133patient 032, cancer, homogenized [OPG study]5.837956
GSM549139patient 042, cancer, homogenized [OPG study]5.8039655
GSM549099patient 107, normal, homogenized [OPG study]7.832981
GSM549109patient 139, normal, homogenized [OPG study]7.8962181
GSM549110patient 046, normal, homogenized [OPG study]7.8795881
GSM549114patient 063, normal, homogenized [OPG study]8.6293485
GSM549122patient 082, normal, homogenized [OPG study]7.6962579
GSM549134patient 033, cancer, homogenized [OPG study]7.2327474
GSM549136patient 036, cancer, homogenized [OPG study]5.5881252
GSM549140patient 044, cancer, homogenized [OPG study]6.2565162
GSM549111patient 047, normal, homogenized [OPG study]6.0141758
GSM549113patient 057, normal, homogenized [OPG study]6.4512565
GSM549132patient 031, cancer, homogenized [OPG study]6.3657963
GSM549137patient 038, cancer, homogenized [OPG study]4.4586828
GSM549142patient 047, cancer, homogenized [OPG study]4.6658730
GSM549100patient 110, normal, homogenized [OPG study]7.8600381
GSM549107patient 135, normal, homogenized [OPG study]7.2841474
GSM549115patient 068, normal, homogenized [OPG study]8.2063682
GSM549116patient 072, normal, homogenized [OPG study]7.7257878
GSM549120patient 078, normal, homogenized [OPG study]8.2374983
GSM549131patient 030, cancer, homogenized [OPG study]6.3288363
GSM549118patient 074, normal, homogenized [OPG study]7.0662172
GSM549129patient 027, cancer, homogenized [OPG study]5.80255
GSM549123patient 088, normal, homogenized [OPG study]7.2121274
GSM549124patient 006, cancer, homogenized [OPG study]5.626152
GSM549126patient 015, cancer, homogenized [OPG study]6.1553861
GSM549128patient 025, cancer, homogenized [OPG study]5.3537947
GSM549103patient 117, normal, homogenized [OPG study]7.3756377
GSM549117patient 073, normal, homogenized [OPG study]8.3174383
GSM549138patient 041, cancer, homogenized [OPG study]6.4809865
GSM549141patient 045, cancer, homogenized [OPG study]4.2750425
GSM549130patient 028, cancer, homogenized [OPG study]6.6855468
GSM549101patient 111, normal, homogenized [OPG study]7.218174
GSM549105patient 128, normal, homogenized [OPG study]7.7588579
GSM549106patient 134, normal, homogenized [OPG study]4.5486131
GSM549112patient 048, normal, homogenized [OPG study]8.022881
GSM549125patient 011, cancer, homogenized [OPG study]5.7396254
GSM549127patient 024, cancer, homogenized [OPG study]5.4204648
GSM549135patient 035, cancer, homogenized [OPG study]5.8620356